News & Updates

Show Multimedia Only
Male sex tied to better outcomes in early ACPA-negative rheumatoid arthritis
Male sex tied to better outcomes in early ACPA-negative rheumatoid arthritis
10 Sep 2022

Men with anticitrullinated peptide antibody (ACPA)-negative early rheumatoid arthritis (RA) tend to have favourable clinical outcomes than their female counterparts, a study has shown. However, such benefit is not seen in those with ACPA-positive early RA.

Male sex tied to better outcomes in early ACPA-negative rheumatoid arthritis
10 Sep 2022
Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
Thrombocytopaenia, platelet dysfunction common in Parkinson’s disease
10 Sep 2022
COVID-19 lockdown weakens metabolism in people with glucose intolerance
COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022

In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.

COVID-19 lockdown weakens metabolism in people with glucose intolerance
10 Sep 2022
Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
09 Sep 2022

In patients with metastatic colorectal cancer (mCRC), using trifluridine/tipiracil with bevacizumab is a safe and effective treatment for refractory disease, a recent study has found.

Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC
09 Sep 2022
Low-dose methotrexate-related melanoma risk considered negligible
Low-dose methotrexate-related melanoma risk considered negligible
09 Sep 2022